CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Millions	Total	Total Crown Equity	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2023	$ 2,864	$ 2,410	$ 604	$ 17	$ 3,476	$ (1,687)	$ 454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	93	67			67		26
Other comprehensive income	13	16				16	(3)
Dividends declared	(45)	(30)			(30)		(15)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	12	12		12
Common stock repurchased	(5)	(5)		(5)
Balance at end of period at Mar. 31, 2024	2,932	2,470	605	23	3,513	(1,671)	462
Balance at beginning of period at Dec. 31, 2023	2,864	2,410	604	17	3,476	(1,687)	454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	168
Other comprehensive income	232					230
Balance at end of period at Sep. 30, 2024	3,045	2,532	599	0	3,390	(1,457)	513
Balance at beginning of period at Mar. 31, 2024	2,932	2,470	605	23	3,513	(1,671)	462
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	207	174			174		33
Other comprehensive income	(114)	(114)				(114)	0
Dividends declared	(55)	(30)			(30)		(25)
Stock-based compensation	8	8		8
Common stock issued	1	1		1
Common stock repurchased	(2)	(2)		(2)
Balance at end of period at Jun. 30, 2024	2,977	2,507	605	30	3,657	(1,785)	470
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(132)	(175)			(175)		43
Other comprehensive income	333	328				328	5
Dividends declared	(35)	(30)			(30)		(5)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	12	12		12
Common stock repurchased	(110)	(110)	(7)	(41)	(62)
Balance at end of period at Sep. 30, 2024	3,045	2,532	599	0	3,390	(1,457)	513
Balance at beginning of period at Dec. 31, 2024	3,228	2,756	594	0	3,624	(1,462)	472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	227	193			193		34
Other comprehensive income	(35)	(35)				(35)
Dividends declared	(58)	(30)			(30)		(28)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	14	14		14
Common stock issued	1	1		1
Common stock repurchased	(205)	(205)	(11)	(14)	(180)
Balance at end of period at Mar. 31, 2025	3,172	2,694	584	0	3,607	(1,497)	478
Balance at beginning of period at Dec. 31, 2024	3,228	2,756	594	0	3,624	(1,462)	472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	682
Other comprehensive income	36					35
Balance at end of period at Sep. 30, 2025	3,499	3,016	579	0	3,864	(1,427)	483
Balance at beginning of period at Mar. 31, 2025	3,172	2,694	584	0	3,607	(1,497)	478
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	216	181			181		35
Other comprehensive income	43	41				41	2
Dividends declared	(64)	(30)			(30)		(34)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	12	12		12
Common stock repurchased	(7)	(7)	(1)	(6)
Balance at end of period at Jun. 30, 2025	3,372	2,891	584	5	3,758	(1,456)	481
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	239	214			214		25
Other comprehensive income	28	29				29	(1)
Dividends declared	(52)	(30)			(30)		(22)
Stock-based compensation	11	11		11
Common stock repurchased	(105)	(105)	(5)	(22)	(78)
Purchase of noncontrolling interests	6	6		6
Balance at end of period at Sep. 30, 2025	$ 3,499	$ 3,016	$ 579	$ 0	$ 3,864	$ (1,427)	$ 483